Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (2) , 190-192
- https://doi.org/10.1016/0959-8049(93)90171-b
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1991
- Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.Journal of Clinical Oncology, 1990
- Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy.Journal of Clinical Oncology, 1989
- Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)Blood, 1988
- Clinical features and management of malignant histiocytosis of the intestineCancer, 1987
- Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosisEuropean Journal of Cancer and Clinical Oncology, 1983
- Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)Cancer, 1982
- IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapyBlood, 1982
- Nodular malignant lymphomas.Factors affecting complete response rate and survivalCancer, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958